It was recently demonstrated that Myc-induced ADHFE1 forming r-2HG is the main cause of the resulting metabolic reprogramming involving reductive carboxylation glutaminolysis and enhancing mesenchymal transition upon changed epigenetics of breast cancer cells. The gene discussed is MYC; the disease is breast carcinoma.